Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Beam Therapeutics Inc (NASDAQ: BEAM) closed at $25.59 in the last session, down -1.27% from day before closing price of $25.92. In other words, the price has decreased by -$1.27 from its previous closing price. On the day, 0.84 million shares were traded. BEAM stock price reached its highest trading level at $25.99 during the session, while it also had its lowest trading level at $24.3245.
Ratios:
We take a closer look at BEAM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.69 and its Current Ratio is at 5.69. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
On November 06, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $27 to $39.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 30 ’25 when Evans John M. sold 30,000 shares for $26.75 per share. The transaction valued at 802,484 led to the insider holds 908,659 shares of the business.
JOHN M EVANS bought 30,000 shares of BEAM for $802,482 on Jan 30 ’25. On Jan 02 ’25, another insider, Bellon Christine, who serves as the Chief Legal Officer of the company, sold 1,241 shares for $24.68 each. As a result, the insider received 30,628 and left with 102,968 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2118995328 and an Enterprise Value of 1273073920. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.06 while its Price-to-Book (P/B) ratio in mrq is 2.67. Its current Enterprise Value per Revenue stands at 3.641 whereas that against EBITDA is -7.916.
Stock Price History:
The Beta on a monthly basis for BEAM is 1.91, which has changed by -0.070301294 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -2.92%, while the 200-Day Moving Average is calculated to be 1.77%.
Shares Statistics:
According to the various share statistics, BEAM traded on average about 1.19M shares per day over the past 3-months and 903940 shares per day over the past 10 days. A total of 82.56M shares are outstanding, with a floating share count of 72.58M. Insiders hold about 12.35% of the company’s shares, while institutions hold 86.86% stake in the company. Shares short for BEAM as of 1736899200 were 10786501 with a Short Ratio of 9.08, compared to 1734048000 on 10057155. Therefore, it implies a Short% of Shares Outstanding of 10786501 and a Short% of Float of 17.040001.
